What the 2025 Election Means for Australian Business: Policy and Funding Highlights
Research and Development Intellect Labs Research and Development Intellect Labs

What the 2025 Election Means for Australian Business: Policy and Funding Highlights

From the $22.7B Future Made in Australia agenda to the promise of new funding for innovation, manufacturing, and SMEs, the re-election of the Albanese Labor government is expected to see a raft of programs and policies implemented to support Australian businesses. We've summarised what the next term has in store with a focus on the already announced support for its national industry priorities, as well as policies and programs that might further R&D and innovation.

Read More
R&D Tax: Excluded Activities
Research and Development Intellect Labs Research and Development Intellect Labs

R&D Tax: Excluded Activities

The R&D Tax Incentive expressly excludes certain activities from qualifying as ‘core R&D activities’. However, these excluded activities can still qualify as supporting R&D activities if a sufficient nexus to the conduct of the core R&D activity can be established. A recent Administrative Review Tribunal ruling has helpfully clarified that medical and health related research, even when involving behavioural aspects, is not excluded and is capable of being registered as an eligible core R&D activity.

Read More
R&D Tax Incentive update: Gambling and Tobacco Companies no longer welcome
Research and Development Intellect Labs Research and Development Intellect Labs

R&D Tax Incentive update: Gambling and Tobacco Companies no longer welcome

The Australian Federal Government has announced as part of the 2024-25 Mid-Year Economic and Fiscal Outlook that gambling and tobacco companies will no longer be able to access the R&D Tax Incentive. The move is indicative of the government seeking to align public funding with societal objectives, reducing indirect subsidies to industries linked to public harm but raising concerns about future industry-specific restrictions.

Read More
Reviewing the latest data on Australia's innovation performance.
Research and Development Stephanie Varidel Research and Development Stephanie Varidel

Reviewing the latest data on Australia's innovation performance.

The outcomes from the latest Australian Innovation Statistics appear positive at first glance. In case you missed it, we provide a summary of the highlights from this recent report. We also dig a little deeper to see that despite some positive indications, there are some concerning signs regarding Australia's innovation performance that should provide pause for thought and consideration of how businesses undertaking R&D can be better supported.

Read More
Streamlining R&D Tax Claims for Clinical Trials in Australia
Research and Development Intellect Labs Research and Development Intellect Labs

Streamlining R&D Tax Claims for Clinical Trials in Australia

Clinical trials have long been viewed favourably under the R&D Tax Incentive Program. To recognise this, the program offers an efficient registration process for trials registered with the Therapeutic Goods Administration, reducing the administrative burden for biotech companies. This streamlined approach, along with support through Advance Overseas Findings (AOF), empowers Australian biotech firms to innovate and lead on the global stage.

Read More
How to Successfully Navigate the Overseas Finding Process for R&D Tax Incentives
Research and Development Intellect Labs Research and Development Intellect Labs

How to Successfully Navigate the Overseas Finding Process for R&D Tax Incentives

The Overseas Finding process is a crucial component of the Research & Development Tax Incentive (RDTI) in Australia, enabling companies to access a tax benefit for overseas activities that relate to an Australian R&D program. This guide explores the Overseas Finding process, the key conditions for eligibility, and recent ATO concerns as outlined in taxpayer alerts. We also highlight a successful case study with a cyber security innovator, Internet 2.0, to illustrate effective strategies for securing an Overseas Finding.

Read More
R&D Tax Incentives and the SME Turnover Dilemma
Research and Development Intellect Labs Research and Development Intellect Labs

R&D Tax Incentives and the SME Turnover Dilemma

The R&D Tax Incentive remains Australia’s primary program for supporting businesses undertaking R&D activities with an estimated $3.2 billion annual investment. The program uses a $20 million annual turnover threshold to determine a company’s R&D tax rebate, a threshold that has been unchanged since 2011. In our view, it is time to review this arbitrary line in the sand and ensure the R&DTI aligns with other SME policies so that highly innovative medium sized businesses are incentivised to continue their R&D investment as they grow.

Read More